Ardena Expands US Footprint With New GLP Bioanalytical Laboratory In New Jersey

Ardena, a specialist CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, announces that its new state-of –the-art ...

April 17, 2026 | Friday | News
Illumina and D3b Launch Landmark Pediatric Genomics Dataset to Accelerate Precision Medicine

Dataset will drive crucial insights to accelerate scientific discovery and ultimately improve pediatric patient care.  Illumina (NASDAQ: ILMN) and...

April 16, 2026 | Thursday | News
Telix Advances First Radiopharmaceutical Therapy Into Phase III For Glioblastoma Treatment

Telix Pharmaceuticals Limited announces that the first patient has been dosed with TLX101-Tx (¹³¹I-iodofalan) in Telix’s pivota...

April 16, 2026 | Thursday | News
Sana Biotechnology and Mayo Clinic Partner to Advance SC451 Cell Therapy for Type 1 Diabetes

Sana and Mayo Clinic to collaborate across multiple areas with goal of accelerating development of and access to potentially curative therapies for patie...

April 15, 2026 | Wednesday | News
Renaissance Pharma Secures FDA Fast Track and IND Clearance for Daretabart in High-Risk Neuroblastoma

FDA grants Fast Track Designation for Daretabart (hu1418K322A), recognising the significant unmet medical need in high-risk neuroblastoma and enabling ...

April 15, 2026 | Wednesday | News
Novo Nordisk Partners with OpenAI to Lead AI-Driven Transformation Across Drug Discovery and Operations

Strategic partnership enables upskilling of Novo Nordisk’s workforce and places the company at the forefront of AI transformation in healthcare ...

April 15, 2026 | Wednesday | News
Thermo Fisher Scientific Expands PPD™ Clinical Research Capabilities Through Strategic Data Collaboration with HealthVerity

Thermo Fisher Scientific, the world leader in serving science, announced a strategic data collaboration with HealthVerity, a leading real-world data (RWD...

April 15, 2026 | Wednesday | News
SynOx Therapeutics Reports Strong Phase 3 TANGENT Results With Emactuzumab In TGCT

TANGENT met its primary and secondary endpoints with a high level of statistical significance vs. placebo at 6 months, including ORR by RECIST V1.1 and...

April 14, 2026 | Tuesday | News
OncoC4 Initiates Phase 1/2 Trial of Anti-SIGLEC 10 Antibody in Alzheimer’s Disease

OncoC4 Inc., a late clinical stage biopharmaceutical company, announced first participant's dosing following the clearance of the Investigational New Dru...

April 13, 2026 | Monday | News
GenScript and Mimulus Partner to Industrialize DNA Data Storage for the AI Era

The multi-year collaboration aims to scale molecular data storage infrastructure and unlock breakthrough cost efficiencies by 2030. GenScript Biotech Co...

April 13, 2026 | Monday | News
Virica and FUJIFILM Biosciences Collaborate to Boost AAV Manufacturing Efficiency

Efficient production of Adeno-Associated Virus (AAV) vectors at scale for in vivo gene therapies remains a key bottleneck for broad patient access an...

April 10, 2026 | Friday | News
Novartis Scales Global Community Health Efforts to Tackle Gaps in Chronic Disease Care

Strengthens three community health models spanning community‑embedded care, earlier intervention and data‑driven population health Scales program ...

April 10, 2026 | Friday | News
NexTel Medical Corp Initiates First Phase of Global Rollout for Exosome-Based Cancer Screening Test

NexTel Medical Corp f/k/a Exousia Pro, Inc. (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery syste...

April 09, 2026 | Thursday | News
Mesoblast Limited Secures U.S. Food and Drug Administration IND Clearance for Registrational Trial of Ryoncil in Duchenne Muscular Dystrophy

Partnering with Parent Project Muscular Dystrophy to ensure timely access to the trial for eligible patients ~15,000 children are living with DMD in the...

April 09, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close